Methods for treating tweak-related conditions
CA 2480745 A1 · Owner: Biogen Ma Inc. · Inventors: Burkly, Linda; Zheng, Timothy; Jakubowski, Aniela
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods and agents for the treatment of TWEAKrelated conditions, including cardiac, liver kidney, lung, adipose, skeletal, muscle neuronal, bone and cartilage conditions. The invention also provides methods for identifying TWEAK agonists or antagonists for the treatment of TWEAK-related conditions. Additionally the invention provides transgenic , animals that express an exogenous DNA encoding a TWEAK polypeptide or , fragments, analogs, or muteins thereof and methods for using such animals to identify TWEAK agonists or antagonists. The invention further provides methods for diagnosing a disease based on TWEAK expression. The invention also provides …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 9, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 9, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 9, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.